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OBJECTIVES Our objective was to determine if long-term daily administration of phytonutrient supple-
ments can prevent the immediate adverse impact of a high-fat meal and increase the
production of nitric oxide.
BACKGROUND Ingestion of a high-fat meal impairs flow-mediated vasodilation of the brachial artery for at
least 4 h; however, co-ingestion of vitamin antioxidants or a green salad has been shown to
prevent this effect.
METHODS Flow-mediated brachial artery reactivity test (BART) both before and 3 h after a 900 calorie
50 g fat meal was evaluated in 38 healthy volunteers (age 36.4  10.1 years). Subjects were
randomized to four weeks of daily supplementation with a powdered fruit vegetable juice
concentrate (Juice Plus [JP]) along with a complex supplement providing nutritional
antioxidants and various herbal extracts (Vineyard [V]), JP alone, or a matching placebo. At
three and four weeks, BART was repeated both before and after the high-fat meal. Serum
nitrate/nitrite concentrations were measured at baseline and at four weeks.
RESULTS Four weeks of the JP-V combination blunted the detrimental effect of the high-fat meal
(47.5  23.4% at baseline vs. 1.7  9.7% at four weeks [p  0.05]). Four weeks of JP
alone had a similar beneficial effect (45.1  19.7% at baseline vs. 16.6  10.3% at four
weeks [p  0.05]), whereas there was no substantial effect of the placebo. In the subjects
treated with supplements, concentrations of serum nitrate/nitrite increased from 78  39 to
114  62 m/l (p  0.02).
CONCLUSIONS Daily ingestion of modest amounts of a fruit/vegetable juice concentrate with or without
adjunctive phytonutrient supplementation can reduce the immediate adverse impact of
high-fat meals on flow-mediated vasoactivity and increase nitrate/nitrite blood concen-
tration. (J Am Coll Cardiol 2003;41:1744–9) © 2003 by the American College of Cardiology
Foundation
A high intake of fruits and vegetables has been associated
with reduced risk for coronary heart disease and ischemic
stroke in large prospective case-control studies (1–5). The
mechanisms by which fruit and vegetable consumption
achieves this benefit remain to be established. They can
provide a substantial ration of dietary potassium and soluble
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fiber and are typically rich in a range of antioxidant
phytonutrients. Previous studies show that antioxidant vi-
tamins—notably C and E—can often exert a favorable
effect on endothelial function (6–11). In particular, they
appear to help preserve the endothelium’s capacity to
generate bioactive nitric oxide (NO) in various pathogenic
circumstances that tend to impair this activity. Nitric oxide
acts to stabilize platelets, promote vasodilation, inhibit
smooth muscle migration and hyperplasia, and maintain an
anti-inflammatory endothelial phenotype that discourages
the influx of activated monocytes and other inflammatory
cells. To the extent that dietary antioxidants can offset the
harmful impact of endothelial oxidants on NO bioactivity,
they have the potential to make an important contribution
to vascular health (11).
A sudden increase in the shear stress acting on arterial
endothelium induces an endothelium-dependent, NO-
mediated vasodilation that is susceptible to non-invasive
quantitation by high-frequency ultrasound techniques
(12,13). Flow-mediated vasodilation (FMV) of the brachial
artery, evoked by the hyperemia that follows relief of
pressure-cuff occlusion of arterial blood flow, is now com-
monly measured to assess the endothelium’s capacity for
generating bioactive NO in conduit arteries. This FMV is
often impaired in patients expressing coronary risk factors
associated with endothelial dysfunction, such as hypercho-
lesterolemia, hypertension, hyperhomocysteinemia, insulin
resistance, diabetes, and angina (14–24). Our group has
previously demonstrated that this vasodilation is transiently
impaired for up to 4 h after the ingestion of a fatty meal,
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presumably owing to the impact of triglyceride-rich lipopro-
teins and/or high free fatty acid levels (7,25,26); this finding
has been confirmed by others (27–32). We have also found
that if ample doses of vitamins C and E are administered in
conjunction with a fatty meal, the subsequent deterioration
of FMV is substantially prevented (7); this suggests that
induced endothelial oxidant stress mediates all or most of
the adverse impact of the high-fat meal. The objective of
this study is to determine whether long- or short-term
administration of fruit and vegetable concentrates rich in a
range of antioxidant phytochemicals could provide a com-
parable benefit.
METHODS
Patient population. Thirty-eight healthy, physically active
hospital employees—14 men and 24 women—age 36.4 
10.1 years (mean  SD) were studied. None of the subjects
had a history of coronary heart disease, hypertension,
diabetes mellitus, or tobacco abuse. Written informed con-
sent was obtained from all subjects, and the protocol was
approved by the Institutional Review Board of the Univer-
sity of Maryland at Baltimore.
Baseline evaluation. Studies were begun at 8 AM after a
12-h overnight fast. Fasting blood was drawn for serum
total, low-density lipoprotein (LDL) cholesterol, high-
density lipoprotein cholesterol, triglycerides, and homocys-
teine. These assays were performed in the hospital’s clinical
chemistry laboratory. Combined serum nitrate/nitrite con-
centrations were determined by a two-step reaction. Each
determination required the use of 40 l of undiluted plasma.
The first step consisted of an enzymatic conversion of
nitrate to nitrite utilizing nitrate reductase. The second step
is the addition of Greiss reagent that converts nitrite to a
deep purple azo chromophore, which is quantified at
540 nm and compared to a series of nitrite standards.
Homocysteine levels were measured by the high-
performance liquid chromatography method. Brachial ar-
tery vasodilation was assessed at baseline and after a high-fat
meal.
Evaluation of endothelial function. Flow-mediated bra-
chial artery vasodilation was measured using a previously
described non-invasive technique (7). Briefly, FMV was
assessed in the subject’s left arm in the recumbent position
in a temperature-controlled room (22°C) after a 10-min
equilibration period by a single dedicated ultrasonographer.
With use of 7.5-MHz linear array ultrasound, the brachial
artery was longitudinally imaged approximately 5 cm prox-
imal to the antecubital crease, twice at baseline and then 1
min after release of 5 min of upper arm arterial occlusion
with a 12.5-cm-wide blood pressure cuff. Photographic
images of end-diastolic frames were obtained and were
analyzed by two independent investigators blinded to the
subject’s identity and temporal sequence. Arterial diameter
was determined by caliper measurement at the single most
equivalently imaged site using side-by-side presentation.
Blood pressure and heart rate were also measured.
Flow-mediated vasodilation was quantified as the percent
of diameter change of the post-occlusion arterial diameter
measurement relative to the mean of the corresponding two
baseline measurements. The means of the two measure-
ments by independent observers were calculated. The re-
producibility of the two baseline measurements (SD of
difference) was 0.87% (coefficient of variation, 4.3%).
After this, the subjects ate a high-fat meal and were
re-studied 3 h after consumption of the meal. The high-fat
meal (3,766 kJ [50 g of fat, 14 g of saturated fat, 225 mg of
cholesterol]) consisted of an Egg McMuffin, Sausage Mc-
Muffin, two hash brown patties (McDonald’s Corporation),
and a non-caffeinated beverage.
Randomization. The subjects were then randomized in a
double-blind and 2:2:1 fashion to one of three regimens:
Juice Plus (JP), Juice Plus and Vineyard (JP-V), or placebo.
Juice Plus is a commercially available capsule supplement
providing dried juice concentrates derived from a variety of
fruits and vegetables. The fruit concentrate was derived
from apples, oranges, pineapples, papaya, cranberries, and
peaches. The vegetable concentrate was derived from car-
rots, parsley, beets, broccoli, kale, cabbage, spinach, and
tomatoes. Vineyard is a proprietary capsule supplement
incorporating arginine hydrochloride, coenzyme Q10,
L-carnitine, mixed tocopherols, ascorbic acid, dried berry
juices and extracts, and multiple herbal extracts, including
ginkgo biloba, hawthorn berry, grape skin, grape seed, and
green tea. Many of these ingredients possess antioxidant
activity, and arginine supports effective endothelial produc-
tion of NO. Table 1 provides the vitamin composition of V
and of JP. Two opaque capsules were taken twice a day in a
double-blind manner for a four-week period after the
Abbreviations and Acronyms
BART  brachial artery reactivity test
FMV  flow-mediated vasodilation
JP  Juice Plus
LDL  low-density lipoprotein
NAD(P)H  nicotinamide adenine dinucleotide
phosphate (reduced)
NO  nitric oxide
V  Vineyard
Table 1. Assayed Vitamin and Nitrate Content of Juice Plus
and Vineyard
Juice Plus (4 capsules) Vineyard (4 capsules)
Beta-carotene (i.u.) 9,275 7,188
Vitamin C (mg) 20.4 51
Vitamin E (mg) 24.7 30.4
Thiamin HCL (mg) 0.75 0.17
Riboflavin (mg) trace 0.03
Niacin (mg) 0.37 1.3
Pyridoxine (mg) 0.07 0.35
Nitrate (mg) 5.7 0.76
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baseline study. The capsules were withheld on the morning
of the four-week study.
Follow-up studies. Subjects were studied at three weeks
(taking the morning dose) and at four weeks (omitting the
morning dose). All fasting blood studies performed at
baseline were repeated at four weeks. Brachial artery studies
were performed similarly to those performed before ran-
domization.
Statistical analysis. Group values are expressed as mean 
SD. Two-tailed paired t test was used to compare changes
in individual subjects, and two-tailed non-paired t tests were
used to compare values between groups. A p value 0.05
was considered significant.
RESULTS
Preprandial diameter at baseline (before randomization) was
2.7  0.2, 3.1  0.5 mm, and 3.1  0.6 mm, and blood
pressure was 113 6/71 7 mm Hg, 116 6/73 6 mm
Hg, and 116 9/73 7 mm Hg in subjects randomized to
placebo, JP, or combined JP-V, respectively. These values
did not change significantly over the four weeks of the
study.
Preprandial and postprandial FMV determinations at
baseline (before randomization) and at three and four weeks
in the three groups are shown in Table 2. The postprandial
percent of FMV compared with the preprandial value (mean
 SD) decreased 40.9  17.9% in the placebo group,
45.1 19.7% in the JP group, and47.5 23.4% in the
combined JP-V group. Differences among the groups at
baseline were not statistically significant. There was a trend
for the pre-meal FMV to decrease over time, but this did
not reach statistical significance. Figure 1 shows the percent
of decrease in vasoactivity from preprandial to postprandial
for each of the three groups.
In the placebo group, the percent of decrease in vasoac-
tivity with the high-fat meal remained high at three and
four weeks (37.1  19.7% and 37.6  23.4%, respec-
tively). In the JP and JP-V group at both three and four
weeks, the percent of decrease in postprandial vasodilation
was significantly less than the decrease found before sup-
plementation. The percent of decrease in the JP group after
the high-fat meal was 22.3  12.6% at three weeks and
16.6  10.3% at four weeks (p  0.05 compared with the
baseline values). The percent of decrease in the JP-V group
after the high-fat meal was 13.7  10.2% at three weeks
(p  0.05) and only 1.7  9.7% at four weeks (p  0.02
compared with baseline values). Thus, JP and JP-V at three
and four weeks significantly decreased the detrimental effect
of the high-fat meal on endothelial function.
Lipoprotein, homocysteine, and serum nitrate/nitrite de-
terminations at baseline and at four weeks are shown in
Table 3. Total cholesterol and LDL cholesterol decreased
significantly (p  0.05) in the group that received JP over
the four-week study period, but they did not change in the
groups taking JP-V or placebo. There were no changes in
other lipoproteins or homocysteine in any group. There was
a trend for serum nitrate/nitrite levels to increase in each of
the active-treatment groups. When these two groups were
combined, serum nitrate/nitrite levels rose from 78  39
m/l to 114  62 m/l (p  0.02). There was no
significant correlation between the increase in these levels
and the change in vasodilation.
DISCUSSION
This study found that the daily use for four weeks of a
fruit/vegetable juice concentrate, rich in antioxidant phyto-
chemicals, blunted the detrimental impact of a single
high-fat meal on the endothelial function of healthy sub-
jects; similar results were seen with a more complex supple-
Table 2. Percent Change in Diameter Before and After High-Fat Meal
Baseline 3 Weeks 4 Weeks
Fasting 3 h Postprandial Fasting 3 h Postprandial Fasting 3 h Postprandial
Placebo (n  10) 20.2  4.2 11.7  5.4* 15.7  5.2 9.9  4.9* 15.3  5.3 10.2  4.7*
Juice Plus (n  14) 13.2  4.2 7.63  3.7* 9.4  4.6 6.4  4.8† 9.7  5.7 7.4  4.0†
Juice Plus and Vineyard
(n  12)
15.8  6.7 8.0  4.5* 15.8  7.1 12.4  4.8† 12.8  6.2 11.2  4.7†
*p  0.05 versus fasting; †not significant versus fasting level.
Figure 1. Postprandial decreases on brachial artery vasoactivity at 0, 21,
and 28 days after a single high-fat meal in patients randomized to placebo,
JP, or JP-V supplementation. *p 0.05, †p 0.02 compared with baseline
(day 0). Solid bars  day 0; shaded bars  day 21; open bars  day 28.
JP  Juice Plus; V  Vineyard.
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mentation regimen incorporating various nutrients and
herbal extracts in addition to the fruit/vegetable juice
concentrate. This extends our previous observation that
pretreatment with a single dose of antioxidant vitamins is
effective when taken immediately before a high-fat meal (7).
The present design enables us to conclude that prolonged
antioxidant phytochemical supplementation can exert a
long-term effect such that endothelial function is protected
from the adverse impact of a fatty meal even if antioxidants
are not administered with that meal. It is interesting to note
that, whereas the supplementation provided in this study
provided only modest doses of any one antioxidant, the
cumulative effect of these antioxidants appeared at least
comparable to the protection afforded by large doses of two
supplemental antioxidants in our previous study.
Although many previous studies have demonstrated that
supplemental intakes of vitamins C and E can benefit
impaired endothelium-dependent vasodilation (6–11), rel-
atively few reports are available evaluating the potential of
food phytochemicals in this regard. We previously have
reported that incorporation of a dark green salad into an
olive oil–rich meal offsets the adverse impact of the olive oil
on endothelial function (26). Another report indicates that
long-term ingestion of a 40% fat diet impairs brachial artery
FMV but that daily ingestion of red wine—known to be
rich in antioxidant polyphenols—prevents this effect (33).
In patients with coronary disease, ingestion of purple grape
juice for 14 days likewise has a favorable impact on FMV
(34). In these studies with wine and grape juice, endothe-
lium function was assessed in the morning under fasting
conditions, without immediate pre-administration of the
protective food; thus, their findings are concordant with
ours.
Endothelial dysfunction is often associated with, and at
least in part mediated by, increased endothelial superoxide
generation (11,35). The demonstrable utility of antioxidant
vitamins for blunting the adverse impact of fatty meals on
endothelial function suggests that enhanced endothelial
superoxide production may mediate the concurrent impair-
ment of FMV. The fact that superoxide production by
stimulated leukocytes increases sharply after such meals
(30,31) is seemingly consistent with this view, inasmuch as
the membrane-bound NAD(P)H oxidase system appears to
be primarily responsible for superoxide generation in both
leukocytes and endothelium (24,35–39). Furthermore, ex-
posure of endothelial cells to free fatty acids has been shown
to stimulate superoxide production (40,41). Oxidation of
LDL particles renders them more detrimental to endothe-
lial function (42). Thus, there is reason to suspect that an
ample dietary intake of antioxidants may promote endothe-
lial health and, more specifically, limit the adverse influence
of fatty meals on endothelial function. The results of this
study appear consistent with this view.
Owing to the fact that NO has an extremely short
half-life, its production is most conveniently estimated by
measuring serum or urinary levels of its chief metabolic
products, namely nitrate and nitrite. It is interesting to note
that serum levels of nitrate-plus-nitrite increased signifi-
cantly in subjects receiving the active supplements in this
study. This tells us nothing about the impact of such
supplementation on endothelial superoxide production, but
it suggests that endothelial NO synthase activity may be
enhanced in healthy subjects by an increased intake of
phytochemical antioxidants. Because green leafy vegetables
contain nitrates, it’s conceivable that the JP supplement may
have contributed modestly to dietary nitrate intake, but this
is unlikely to account for the magnitude of the observed
increase in serum levels of NO metabolites. Because protein
intake was not specifically controlled for several days before
measurement, serum nitrite/nitrate levels have limited reli-
ability. Nitric oxide is known to be the primary mediator of
flow-induced brachial vasodilation (43); therefore, the fa-
vorable impact of phytochemical supplementation on endo-
thelial function in this study seems likely to reflect preser-
vation of NO bioactivity.
Although antioxidant protection can be provided by high
supplemental intakes of specific antioxidant vitamins—
vitamins C and E have received the most attention in this
regard—there may be limitations to the efficacy of this
approach. In prospective cohort studies, high intakes of
vitamin E have been linked to a notable reduction in
coronary risk (44–46). Nonetheless, except for the small
CHAOS trial (47), randomized primary and secondary
prevention trials evaluating supplemental vitamin E have
demonstrated a lack of beneficial effect of this antioxidant
on cardiovascular events (48–50), in contrast to the notably
Table 3. Lipoprotein, Homocysteine, and Combined Nitrite/Nitrite Levels in 38 Normal





Juice Plus and Vineyard
n  12
Baseline 4 Weeks Baseline 4 Weeks Baseline 4 Weeks
Total cholesterol (mg/dl) 195 36 191 31 184 30 172 22* 185 31 182 24
LDL cholesterol (mg/dl) 123 36 123 25 110 25 100 26* 113 27 113 22
HDL cholesterol (mg/dl) 56 13 53 14 53 16 51 14 54 16 52 13
Triglycerides (mg/dl) 77 32 77 36 104 45 101 73 85 29 84 34
Homocysteine (m/l) 6.2 1.1 5.9 0.7 6.8 0.9 6.8 1.3 8.1 2.1 7.8 2.3
NO (m/l) 63 39 68 31 77 43 110 64† 84 45 115 59†
*p  0.05 versus baseline; †p  0.1 versus baseline. All values are mean  SD.
HDL  high-density lipoprotein; LDL  low-density lipoprotein; NO  nitrate/nitrite serum level.
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favorable impact of statin therapy over the same time span.
Conceivably, this reflects the fact that vitamin E, as a
lipid-soluble antioxidant, can only indirectly influence the
oxidation of water-soluble targets such as tetrahydrobiop-
terin and dimethylarginine dimethylaminohydrolase. Vita-
min C, on the other hand, is a versatile water-soluble
antioxidant, and a sharp increase in plasma vitamin C levels
has often been shown to improve endothelium-dependent
vasodilation. Nonetheless, the membrane transporter pri-
marily responsible for carrying ascorbic acid into endothelial
cells appears to be saturated by plasma ascorbate concentra-
tions—50 to 100 micromolar (51)—that can be achieved
and maintained with a daily intake of about 200 mg (52),
this suggests that the protection achievable with vitamin C,
while worthwhile, may be limited in scope. These consid-
erations suggest that ingestion of a wide range of both
water-soluble and lipid-soluble antioxidants, including but
not limited to vitamins C and E, may represent the most
effective strategy for achieving comprehensive antioxidant
protection of vascular endothelium, and a high intake of
fruits and vegetables is a very practical means of attaining
this goal. The clear evidence from prospective epidemiolog-
ical studies linking high fruit and vegetable intake—
independent of other dietary factors—with reduced coro-
nary risk may in large measure reflect a beneficial impact of
phytochemical antioxidants on endothelial health.
Despite strong clues from epidemiology, the thesis that a
high intake of fruits and vegetables diminishes coronary risk
still requires validation in prospective controlled trials. The
encouraging results of this study suggest that it might be
feasible to use encapsulated fruit and vegetable concentrates,
analogous to the JP product evaluated here, in such a trial.
The merit of this approach is that the study could be
conducted in a double-blind fashion without influencing the
intake of other foods. Of course, further small studies
validating the utility of products such as JP would be
required before it would be prudent to use those products in
massive long-term prospective trials.
The Vineyard product incorporated in one arm of this
study contains a diverse assortment of phytochemicals,
herbs, and nutrients that potentially could influence endo-
thelial function, including 1 g daily of arginine hydrochlo-
ride. The mechanism by which the administered supple-
ments abrogate the adverse impact of fatty meals on
endothelial function has not been determined. We speculate
that the active supplements lessened the impact of oxidative
stress in vascular endothelium and thereby counteracted the
ability of chylomicron remnants and/or free fatty acids to
suppress NO synthase activity and NO bioactivity.
CONCLUSIONS
In conclusion, a high-fat meal causes a temporary decrease
in flow-mediated brachial artery vasodilatation, likely owing
to an induced increase in endothelial oxidative stress. In
healthy volunteers, four weeks of daily supplementation
with a fruit-and-vegetable juice concentrate, with or with-
out an adjunctive complex phytochemical supplement,
blunts the detrimental effect of a high-fat meal on flow-
mediated brachial artery vasodilation—even when the sup-
plement is not administered with the meal—and increases
the combined serum nitrite/nitrate concentration. However,
whether preservation of NO bioactivity mediates the ob-
served benefit is still speculative.
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